Publications & Articles

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1

08 / 20 / 2021

Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1

Nature Cancer, August 2021.

Lucile Vanhersecke, Maxime Brunet, Jean-Philippe Guégan, Christophe Rey, Antoine Bougouin, Sophie Cousin, Sylvestre Le Moulec, Benjamin Besse, Yohann Loriot, Mathieu Larroquette, Isabelle Soubeyran, Maud Toulmonde, Guilhem Roubaud, Simon Pernot, Mathilde Cabart, François Chomy, Corentin Lefevre, Kevin Bourcier, Michèle Kind, Ilenia Giglioli, Catherine Sautès-Fridman, Valérie Velasco, Félicie Courgeon, Ezoglin Oflazoglu, Ariel Savina, Aurélien Marabelle, Jean-Charles Soria, Carine Bellera, Casimir Sofeu, Alban Bessede, Wolf H. Fridman, François Le Loarer & Antoine Italiano.

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker

08 / 18 / 2021

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker

Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance
Annals of Oncology, 2021, Aug. 18.

Y Loriot, A Marabelle, J P Guégan, F X Danlos, B Besse, N Chaput, C Massard, D Planchard, C Robert, C Even, M Khettab, L Tselikas, L Friboulet, F André, I Nafia, F Le Loarer, J C Soria, A Bessede, A Italiano.